Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ4V0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,362
Award facts
- Contract value 100% obligated
- $20,361.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,361.70 by the Defense Logistics Agency on January 6, 2026, for the supply of Trulicity 3 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of January 7, 2026, was competitively awarded without set-aside restrictions and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen's parent company, Cencora, Inc., holds a substantial IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This award demonstrates AmerisourceBergen's continued role as a critical vendor within the federal pharmaceutical supply chain, particularly for military and veteran healthcare systems. The delivery of Trulicity, a diabetes management medication, aligns with the company's extensive portfolio of specialty pharmaceuticals and brand-name drugs supplied through the DLA Medical Supply Chain. The competitive award process and firm fixed-price structure reflect standard federal procurement practices for pharmaceutical commodities, enabling efficient fulfillment of essential medical requirements across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FJ4V0?
SPE2DR26FJ4V0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJ4V0 worth?
The government has obligated $20,362 on SPE2DR26FJ4V0.
Is contract SPE2DR26FJ4V0 an order under another contract?
Yes. SPE2DR26FJ4V0 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ4V0 competed?
The extent of competition for SPE2DR26FJ4V0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award